BTAI
BioXcel Therapeutics Inc
NASDAQ: BTAI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.04
-1.89% today
Updated 2026-04-29
Market cap
$28.70M
P/E ratio
—
P/S ratio
44.70x
EPS (TTM)
$-5.73
Dividend yield
—
52W range
$1 – $8
Volume
1.8M
BioXcel Therapeutics Inc (BTAI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-4,016.00%
ROE
-1,767.00%
ROA
-75.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | — | $-636000.00 | — | — | — |
| 2016 | $0.00 | $-2.12M | — | — | — |
| 2017 | $0.00 | $-4.54M | — | — | — |
| 2018 | $0.00 | $-19.27M | — | — | — |
| 2019 | $0.00 | $-32.34M | — | — | — |
| 2020 | $24.00 | $-82.01M | 100.00% | -342,904,166.67% | -341,700,000.00% |
| 2021 | $0.00 | $-106.63M | — | — | — |
| 2022 | $375000.00 | $-165.76M | 94.67% | -42,572.00% | -44,201.87% |
| 2023 | $1.38M | $-179.05M | 8.70% | -12,447.97% | -12,974.86% |
| 2024 | $2.27M | $-59.60M | 5.43% | -2,967.56% | -2,630.14% |
| 2025 | $642000.00 | $-69.90M | 27.73% | -7,742.21% | -10,887.38% |